Recent studies have additionally shown that GSK3β inhibitors induce growth suppression and apoptosis in human chronic lymphocytic leukemia, glioma, colon cancer and renal cell carcinoma [10], [11], [12], [13]. Here, GSK3B is linked to hereditary clear cell renal cell carcinoma.